Christopher J Winrow
Ironwood Pharmaceuticals, USA
Biography
Christopher Winrow completed his Ph.D. at the University of Alberta and post-doctoral fellowship at the Salk Institute. He has authored 70 publications and has over 15 years of neuroscience drug discovery and development experience, delivering five compounds from HTS through successful clinical proof of concept. He led the Belsomra® discovery team from screening to regulatory approval in less than 10 years, resulting in this first-in-class CNS therapeutic garnering approvals by U.S. and international regulatory agencies. Dr. Winrow is Senior Principal Investigator at Ironwood Pharmaceuticals in Cambridge, MA where he is responsible for leading multidisciplinary teams through proof of concept for clinical-stage compounds.
Abstract
Abstract : Evaluating nitric oxide and soluble guanylate cyclase signalling in vascular dementia